| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1
Department of Imaging, Hammersmith Hospital, Imperial College School of
Medicine, Du Cane Rd., London W12 0HS, United Kingdom.
2
Department of Gynecological Oncology, Hammersmith Hospital, Imperial College
School of Medicine, London W12 0HS, United Kingdom.
3
Department of Histopathology, Hammersmith Hospital, Imperial College School of
Medicine, London W12 0HS, United Kingdom.
OBJECTIVE. Accurate assessment of lymph node status before treatment is critical in the treatment of gynecologic cancers because the 5-year survival and treatment of women is influenced by lymph node involvement. The aims of this study were to investigate the ability of X-ray CT, MR imaging, and 18F-FDG positron emission tomography (PET) to detect pelvic lymph node metastases by comparing imaging with histopathologic findings after lymph node dissection.
MATERIALS AND METHODS. Eighteen patients with gynecologic cancers were studied by all three imaging methods before surgery. The images were initially reviewed with routine diagnostic conditions and then, subsequently, by two observers who were unaware of the clinical and histopathologic findings of the patients. The nodal sites were split into upper (aortic to common iliac bifurcations) and lower (common iliac bifurcations to inguinal ligament) iliac chains. All observers' results were statistically analyzed with specificity, sensitivity, positive and negative predictive values, Fisher's exact test (individual observers) or chi-square test (combined observers), and Cohen's kappa test.
RESULTS. Eight of 18 patients had lymph node metastases at histology. Findings of all three modalities agreed in full in only one patient. CT correctly revealed 10 node-negative patients, whereas MR imaging was correct in eight of these patients. 18F-FDG PET correctly depicted one patient with lymph nodes negative for tumor. CT was the most specific imaging modality (97.0%), with MR imaging and PET rendering values of 90.7% and 77.3%, respectively, but sensitivity of all modalities was low (CT, 48.1%; MR imaging, 53.7%; PET, 24.5%). Observer agreement for each modality was good; kappa values among all observers were 0.88 for CT, 0.85 for MR imaging, and 0.72 for PET.
CONCLUSION. CT is the most specific modality for detecting lymph nodes positive for tumor in gynecologic cancers, whereas MR imaging is the most sensitive. The poor results of PET in the pelvis are attributed to urinary 18F-FDG in the ureters or bladder, which may mask or imitate lymph node metastases.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  Y. Tsunoda, M. Ito, H. Fujii, H. Kuwano, and N. Saito Preoperative Diagnosis of Lymph Node Metastases of Colorectal Cancer by FDG-PET/CT Jpn. J. Clin. Oncol., May 1, 2008; 38(5): 347 - 353. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Sala, S. Wakely, E. Senior, and D. Lomas MRI of Malignant Neoplasms of the Uterine Corpus and Cervix Am. J. Roentgenol., June 1, 2007; 188(6): 1577 - 1587. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-H. Chou, T.-C. Chang, T.-C. Yen, K.-K. Ng, S. Hsueh, S.-Y. Ma, C.-J. Chang, H.-J. Huang, A. Chao, T.-I Wu, et al. Low Value of [18F]-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography in Primary Staging of Early-Stage Cervical Cancer Before Radical Hysterectomy J. Clin. Oncol., January 1, 2006; 24(1): 123 - 128. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Sironi, A. Buda, M. Picchio, P. Perego, R. Moreni, A. Pellegrino, M. Colombo, C. Mangioni, C. Messa, and F. Fazio Lymph Node Metastasis in Patients with Clinical Early-Stage Cervical Cancer: Detection with Integrated FDG PET/CT Radiology, December 1, 2005; 238(1): 272 - 279. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. G. H. Beets-Tan and G. L. Beets Rectal Cancer: Review with Emphasis on MR Imaging Radiology, August 1, 2004; 232(2): 335 - 346. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T.-C. Yen, K.-K. Ng, S.-Y. Ma, H.-H. Chou, C.-S. Tsai, S. Hsueh, T.-C. Chang, J.-H. Hong, L.-C. See, W.-J. Lin, et al. Value of Dual-Phase 2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography in Cervical Cancer J. Clin. Oncol., October 1, 2003; 21(19): 3651 - 3658. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Torizuka, T. Kanno, M. Futatsubashi, H. Okada, E. Yoshikawa, F. Nakamura, M. Takekuma, M. Maeda, and Y. Ouchi Imaging of Gynecologic Tumors: Comparison of 11C-Choline PET with 18F-FDG PET J. Nucl. Med., July 1, 2003; 44(7): 1051 - 1056. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. U. Herborn, T. C. Lauenstein, F. M. Vogt, R. B. Lauffer, J. F. Debatin, and S. G. Ruehm Interstitial MR Lymphography with MS-325: Characterization of Normal and Tumor-Invaded Lymph Nodes in a Rabbit Model Am. J. Roentgenol., December 1, 2002; 179(6): 1567 - 1572. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. A. Siegel, L. P. Adler, R. L. Wahl, A. Williams, N. DeSouza, and A. M. Peters FDG Positron Emission Tomography Detection of Pelvic Nodal Metastases in Gynecologic Cancer Am. J. Roentgenol., March 1, 2002; 178 (3): 762 - 764. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
